Backbone switch to abacavir/lamivudine fixed-dose combination: implications for antiretroviral therapy optimization. [electronic resource]
Producer: 20160310Description: 531-40 p. digitalISSN:- 1121-7138
- Adult
- Anti-HIV Agents -- administration & dosage
- CD4 Lymphocyte Count
- Cytokines -- immunology
- Dideoxynucleosides -- administration & dosage
- Drug Combinations
- Drug Substitution
- Female
- HIV Infections -- drug therapy
- HIV-1 -- drug effects
- Humans
- Lamivudine -- administration & dosage
- Male
- Middle Aged
- Prospective Studies
- Treatment Outcome
- Viral Load -- drug effects
No physical items for this record
Publication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.